Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Vimnerixin

Copy Product Info
😃Good
Catalog No. T38850Cas No. 1418112-77-2
Alias RIST4721, RIST 4721, AZD4721, AZD 4721

Vimnerixin (AZD4721) is an orally administered CXCR2 antagonist for inflammation studies.

Vimnerixin

Vimnerixin

Copy Product Info
😃Good
Purity: 99.52%
Catalog No. T38850Alias RIST4721, RIST 4721, AZD4721, AZD 4721Cas No. 1418112-77-2
Vimnerixin (AZD4721) is an orally administered CXCR2 antagonist for inflammation studies.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$399-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.52%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Vimnerixin (AZD4721) is an orally administered CXCR2 antagonist for inflammation studies.
In vitro
Vimnerixin (RIST4721) inhibited KC-stimulated chemotaxis in a dose-dependent manner. Vimnerixin at 10 nM and 100 nM significantly suppressed chemotaxis, while the inhibitory effect at 1 nM was not evident. Vimnerixin at 1 μM completely blocked KC-induced chemotaxis.
In vivo
In preclinical studies, Vimnerixin underwent systematic pharmacokinetic evaluation in male Sprague-Dawley (SD) rats and beagle dogs via intravenous injection (1 mg/kg) and oral administration, with bile duct cannulation (BDC) experiments conducted to assess its excretion pathways. The results demonstrated that Vimnerixin exhibited low clearance rates (2.4 ml/min/kg in rats, 0.5 ml/min/kg in dogs), low volume of distribution (0.15–0.19 L/kg), and prolonged half-life (3.7 hours for intravenous administration in dogs, extending to 8.4 hours for oral administration). The plasma concentration-time curves were highly consistent between bile-duct-cannulated and non-cannulated groups, indicating minimal influence from enterohepatic circulation.
SynonymsRIST4721, RIST 4721, AZD4721, AZD 4721
Chemical Properties
Molecular Weight472.55
FormulaC19H25FN4O5S2
Cas No.1418112-77-2
SmilesN(S(=O)(=O)N1CC(C)C1)C=2C=C(O[C@@H]([C@H](CO)O)C)N=C(SCC3=CC=C(F)C=C3)N2
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (169.29 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1162 mL10.5809 mL21.1618 mL105.8089 mL
5 mM0.4232 mL2.1162 mL4.2324 mL21.1618 mL
10 mM0.2116 mL1.0581 mL2.1162 mL10.5809 mL
20 mM0.1058 mL0.5290 mL1.0581 mL5.2904 mL
50 mM0.0423 mL0.2116 mL0.4232 mL2.1162 mL
100 mM0.0212 mL0.1058 mL0.2116 mL1.0581 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Vimnerixin | purchase Vimnerixin | Vimnerixin cost | order Vimnerixin | Vimnerixin chemical structure | Vimnerixin in vivo | Vimnerixin in vitro | Vimnerixin formula | Vimnerixin molecular weight